Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that Xpert does not cross‐react with other mycobacterial species (Blakemore 2010; Helb 2010).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Helb 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This represents a substantial reduction in diagnostic delay, thereby permitting real-time decision making and planning of treatment (5).”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Such cases (Xpert-positive but culture-negative) are likely to be true TB positives as corroborated by the high specificity [14,18] and by the fact that the procedure is less prone to contamination due to the closed reaction chamber (real-time PCR technology) of Xpert.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Probable Inference, the Law of Succession, and Statistical Inference
Wilson, E. B. (1927) · Journal of the American Statistical Association · doi:10.1080/01621459.1927.10502953 · Cited by 4,476
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
The association for the advancement of medical instrumentation
(1974) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(74)90035-0 · Cited by 1,031
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525 · cited 1×
“tuberculosis detection (15), this assay was too complex and too prone to operator errors, sample cross-contamination, and biohazards for rapid near-patient use.”
BackgroundEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507 · cited 3×
“Truly rapid results for drug susceptibility tests are particularly important in the management of drug-resistant tuberculosis (13).”
BackgroundMicroscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Cited by
Items 801–900 of 940
Detection of Mycobacterium tuberculosis and Drug Resistance: Opportunies and Challenges in Morocco
Chaoui, I., Abid, M., El, M., & Mzibri, M. D. E. (2012) · InTech eBooks · doi:10.5772/30795 · Cited by 1
Investigation into genotypic diagnostics for mycobacterium tuberculosis
Hoek, K. G. P. (2010) · SUNScholar (Stellenbosch University)
Molecular detection and characterization of drug-resistant Mycobacterium tuberculosis
Engström, A. (2013) · Figshare
Jeong, J.-Y., Lee, S. H., & Jang, S. (2014) · Annals of Clinical Microbiology · doi:10.5145/acm.2014.17.2.42
“Xpert MTB/RIF는 진단법평가연구[4-8,10-24] 총 20편을 근 거로 평가하였고, 수정된 SIGN 도구를 이용한 질평가(level of evidence) 결과 ‘2+’가 10편, ‘2-’가 10편이었다.”
InfluentialResponse to “New Delhi Metallo-β-lactamase (NDM-1): an emerging Threat Among Enterobacteriaceae”
Arya, S. C., & Agarwal, N. (2010) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(10)60140-4
Limanskaya, O. Y., & Лиманский, А. П. (2011) · Cytology and Genetics · doi:10.3103/s0095452711060041
Gutierrez, J. A. (2011) · OpenCommons - UConn (University of Connecticut)
Fortschritte in der bakteriologischen und molekularen Diagnostik der Tuberkulose
Hillemann, D., Richter, E., Andres, S., & Rüsch–Gerdes, S. (2014) · Der Pneumologe · doi:10.1007/s10405-013-0695-2
and Rifampin Resistance Identification in Patients with High Clinical Suspicion 2
Ioannidis, P., Papaventsis, D. C., Karabela, S., Nikolaou, S., Panagi, M., Raftopoulou, E., Konstantinidou, E., Μαρίνου, Ι., & Kanavaki, S. (2011)
Running title: Management of HIV-1-TB
Schutz, C., Meintjes, G., Almajid, F. M., Wilkinson, R. J., & Pozniak, A. (2010)
Belgate, N. O. (2012) · Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista)
Ngabonziza, J. C. S. (2014) · University of Nairobi Research Archive (University of Nairobi)
Gonçalves, M. G. (2011) · BEPA Boletim Epidemiológico Paulista
Bactériologie des mycobactéries responsables d’infections respiratoires
Martin, C., & Maugein, J. (2012) · Encyclopédie médico-chirurgicale. Pneumologie · doi:10.1016/s1155-195x(12)48082-3
de Lauzanne, A., Doit, C., Bonacorsi, S., Fitoussi, F., Boman, F., Lorrot, M., Faye, A., & Bingen, É. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820243f3
ДИСКРИМІНАЦІЯ ЗБУДНИКА СИБІРКИ ВІД БЛИЗЬКОСПОРІДНЕНИХ ВИДІВ
Klee, S. R. (2013)
Rapid Molecular Detection of Tuberculosis
Lam, J. T., & Laugwitz, D. K.-L. (2011)
Yurdakul, P., & Çolakoğlu, Ş. (2013) · Methods in molecular biology · doi:10.1007/978-1-4614-9437-9_13
A Review of Isothermal Nucleic Acid Amplification Technologies
Nixon, G. J., & Bushell, C. A. (2013) · CRC Press eBooks · doi:10.1201/b14930-33 · Cited by 1
Hattingh, M., & Bam, L. (2016)
A Binary Approach for Selective Recognition of Nucleic Acids and Proteins
Cornett, E. M. (2015) · STARS (University of Central Florida)
Damoah, R. (2016) · Brandeis Institutional Repository · Cited by 1
Tuberculose pulmonar paucibacilar em Centros de Detenção Provisória
Cergole-Novella, M. C., Carmo, A. M. D. S., Redondaro, A. A. D. A., Candido, V. D. S., Buzon, M. C. D. S., Gonçalves, A. P. D. C., Chimara, É., & Silva, R. R. F. E. (2016) · REVISTA DO INSTITUTO ADOLFO LUTZ · doi:10.53393/rial.2016.v75.33507
Bholla, M. (2016) · edoc (University of Basel) · doi:10.5451/unibas-006672107
New Diagnostic Tools for Early Detection of TB
Zhao, Y., & Wang, S. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6667-7_17
Role of Gene Xpert in Early Diagnosis and Treatment of Tuberculosis
Kar, H., Pachpute, S., Patil, P., Patil, Y., & Urhekar, A. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-53556-2_63
Mbano, I. (2015) · ResearchSpace (University of KwaZulu-Natal)
Cellulose Based Genoassays for the Detection of Pathogen DNA
Saikrishnan, D. (2014) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.14703
Ask the Experts: Managing TB in clinical practice and the impact on transmission
Zellweger, J.-P. (2014) · doi:10.2217/ebo.13.576
Approches optimisées du diagnostic de la tuberculose
Diafouka, M. P.-A. (2018) · theses.fr (ABES) · doi:10.70675/116d8e70z9ad5z4edczbf24z9831825edf95 · Cited by 1
Rapid Point‐of‐Care Diagnostic Tests for Tuberculosis
Lessells, R. J. (2019) · Wiley eBooks · doi:10.1002/9781119282686.ch5
"RETROSPECTIVE ANALYSIS OF XPERT MTB/RIF IN IRL KARNATAKA UNDER RNTCP"
Prasad.A, K., & Bharathidasan (2019) · International Journal of Engineering Applied Sciences and Technology · doi:10.33564/ijeast.2019.v04i02.016
“[9] Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K,;(2010); Rapid detection of Mycobacterium tuberculosis and rifampicin resistance by use of ondemand, near-patient technology.”
BackgroundMethodMohapatra, N., Mohapatra, G., Das, S., Mohanty, C. B. K., & Mohapatra, J. (2019) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2019/460
Mosabebi, N., Sadrnia, M., & Zolfaghari, M. R. (2014) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences
Bairwa, M. C., Fatehpuria, C. M., & Banera, M. K. (2019) · IJAR - Indian Journal of Applied Research
The Challenge of Drug-Resistant Tuberculosis: An Update
Kumar, C., Shrivastava, K., Gupta, S., & Basil, M. V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9449-3_2
Mittal, S., Vohra, D. K., & Mittal, P. (2020) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2020/27
Genexpert data for Rifampicin resistance in Swaziland - a retrospective analysis from 2012-2016
Zanamwe, T. (2019) · Unisa Institutional Repository (University of South Africa)
An Overview of the Drug Susceptibility Testing for Tuberculosis
Jha, V., Kumar, B. A., Panigrahi, S., Nair, G., & Bangera, N. (2020) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2020.03.0653
Gil, H., Margaryan, H., Azamat, I., Ziba, B., Bayram, H., Nazirov, P., Gomez, D. I., Singh, J., Sayfutdinov, Z., Parpieva, N., et al. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13543
“Samples were tested using Xpert MTB/RIF (Cepheid, Sunnyvale, USA) for the detection of Mycobacterium tuberculosis, and the identification of rifampicin resistance following manufacturers’ instructions [9].”
MethodJan, F., Yasin, M., Khan, M. A., Jan, A. T., Samad, A., Jan, A., Ilyas, M., & Khalid, A. (2021) · Pakistan Journal of Chest medicine
Naveed, M., Shahid, M., Hassan, A., Ur-Rehman, M., & Hayat, A. (2019) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2019.06.00215
Bagbi, T., Reema, N., Devi, S. B., Singh, T. G., Jaleel, M., & Nishad, R. (2021) · International Journal of Recent Surgical and Medical Sciences · doi:10.1055/s-0041-1730242
“Cartridge-based nucleic acid amplification test (CBNAAT) assay 12 is a simplified type of automated molecular polymerase chain reaction (PCR) that can detect TB and does screening for multidrug resistance.”
MethodKumar, R., Muni, S., Pankaj, D., Kumar, R., Saurabh, K., Kumar, S., Kumari, N., & Shahi, S. K. (2021) · Journal of Indira Gandhi Institute Of Medical Sciences · doi:10.4103/jigims.jigims_11_21
ETIOLOGY OF LYMPHADENOPTHY AMONG SOUTH INDIAN POPULTION.
Gurusamy, V., Sabrena, M., Asma, A. A., Sudhishnaa, S., & Deepika, S. R. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/4804737
Contribution of bronchoscopic lavage to the diagnosis of smear negative pulmonary tuberculosis
Şahin, M. E., & Bulut, S. (2022) · The European Research Journal · doi:10.18621/eurj.870909
“It has an excellent accuracy when made in sputum and has been approved by the World Health Organization (WHO) [12, 13].”
BackgroundZhao, Y. X., Li, G., Sun, C., Li, C., Wang, X., Liu, H., Zhang, P., Zhao, X., Wang, X., Jiang, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157275
Fraisse, P. (2011) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(11)70050-7
Klinische Anwendungen von mikrobiologischen Schnelltests
Stürenburg, E. (2011) · Springer eBooks · doi:10.1007/978-3-642-20172-1_22
Nucleic Acid Amplification Procedures for Identification from Specimen
Leber, A. L. (2016) · ASM Press eBooks · doi:10.1128/9781555818814.ch7.6.1
Mitarai, S. (2022) · Respiratory disease series · doi:10.1007/978-981-19-3995-2_4
Alom, K. M., Ali, M. M. I., Mahmud, M. J., & Ahmed, M. M. (2023) · Community Based Medical Journal · doi:10.3329/cbmj.v12i1.64292
Laboratory Diagnosis of Tuberculosis
Mali, S., Devnikar, A. V., & Natarajan, A. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_6
Development of advanced diagnostic platform for detection of infectious diseases
Shahdeo, D., Prakashan, D., & Gandhi, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00008-3
Thomas, A. Y., Olivia, N. D., Liomehin, Y., Monemo, P., Tatiana, Y. M., & Vincent, A. H. (2023) · Advances in Infectious Diseases · doi:10.4236/aid.2023.134053
Laboratory Examination for Drug-Resistant Tubercle Bacillus
Zhu, Y., Liu, H., Wang, F., Shan, W., Yin, Q., & Lu, K.-Z. (2023) · Springer eBooks · doi:10.1007/978-981-99-8339-1_3
Nicolás Utrera, Q., Benjamín Zúñiga, P., Pilar Gajardo, O., Natalia Tamblay, N., & Nicolás Pons, C. (2023) · Revista de otorrinolaringología y cirugía de cabeza y cuello · doi:10.4067/s0718-48162023000400402
CBNAAT: An Emerging Xpert in Diagnosis of Head and Neck Tuberculosis
Sahu, R., Prajapati, S., Kumar, A., Aseri, Y., Rawat, D. S., Kuldeep, R., & baniya, R. (2024) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-024-04717-5
Schlanderer, J., Beutler, M., Lüddecke, J., Hoffmann, H., & Paust, N. (2024) · EUROSENSORS Conference (EUROSENSORS) · doi:10.3390/proceedings2024097208
“Only a few fully automated point-of-care solutions are available for TB diagnostics [1,2], and none of them provide extracted DNA for subsequent comprehensive antibiotic resistance testing from the same sample.”
BackgroundNaves, E. F., Andrade, R. L. D. P., de Faria, M. G. B. F., Magnabosco, G. T., Bonfim, R. O., Ferreira, M. R. L., Bóllela, V. R., & Monroe, A. A. (2024) · Texto & Contexto - Enfermagem · doi:10.1590/1980-265x-tce-2023-0288pt
Molecular diagnostic methods for bacteria and fungi detection
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5026-7 · Cited by 1
Strategic diagnosis- Unraveling Tuberculosis- A comprehensive approach
Wazahat, R. (2024) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2024.08.004
Qumbelo, Y., Kachingwe, E., & Omar, S. V. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116504
Liu, L., Wang, C., Mei, B., Wang, J., Xu, X., Zhou, H., & Cai, L. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s473027
“3,4 Xpert has been widely promoted worldwide because of its rapid (approximately 2 hours), accurate, ability to simultaneously detect tuberculosis and RIF-R, and independence from laboratories.”
BackgroundDash, T., Angaj, A. C., & Vishnu, K. A. (2022) · International Journal of Science and Research (IJSR) · doi:10.21275/sr22429110614
Silva, R. S. O., Gomez, R. S., Diniz, M. G., de Miranda, S. S., Aguiar, R. S., Figueredo, L. J. D. A., Buzelin, M. A., Araújo, T. L., & Bernardes, V. F. (2024) · JORDI - Journal of Oral Diagnosis · doi:10.5327/2525-5711.257
Wang, Y., Ma, Z., Dong, X., Wei, S., Wei, M., Cui, J., Liu, Z., Shu, W., Wei, J., Jin, S. K., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5062734
Ochola, E. A., & Mweu, M. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307727 · Cited by 1
Nucleic Acid Amplification Procedures for Identification from Specimens
Baron, E. J., & Gnanashanmugam, D. (2023) · Wiley eBooks · doi:10.1002/9781683670438.cmph0095
Paul, D., Das, P. K., Das, N. S., Chakraborty, G., & Paul, A. (2025) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2025.05.005
Bir, R., Singh, U. B., Gautam, H., Verma, N., Bala, K., Mohan, A., & Guleria, R. (2025) · Cureus · doi:10.7759/cureus.86087
“Conversely, GeneXpert CT values showed no significant correlation with treatment outcomes, likely because CT values measure both live and dead bacterial DNA, which limits their prognostic accuracy [12,20].”
Ou, X., Zhao, B., Zheng, H., Xing, R., Sun, Q., Qin, Z., Zhang, L., Cui, K., Song, Y., Zheng, Y., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1600170
Precision Medicine of Tuberculosis in Africa
Wells, G., Hkimi, C., Zass, L. J., & Kumuthini, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-8959-0_12 · Cited by 1
Garba, D. E., Dibua, U. M. E., Oka, C. U., Ozoadibe, O. Y., Attah, F., & Ajah, M. I. (2025) · Mycobacteria · doi:10.1186/s44350-025-00005-6
“[34] opined that the GeneXpert test demonstrated improved sensitivity in diagnosing MTB and detecting RIF resistant from urine samples.”
The Laboratory Diagnosis of Tuberculosis
Hasan, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-7810-5_45
Notes regarding the next era for the Journal of Clinical Microbiology
Humphries, R. M. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.01647-25
The development of a rapid diagnostic system for difficult to culture human pathogens
Talip, B. A. (2013) · Ulster University Research Portal (Ulster University)
Novel Diagnostic approach for tuberculosis diagnosis
Milovic, A. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 1
Machowski, E. E., Letutu, M., Lebina, L., Waja, Z., Msandiwa, R., Milovanovic, M., Gordhan, B. G., Otwombe, K., Friedrich, S. O., Chaisson, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14650800
Machowski, E. E., Letutu, M., Lebina, L., Waja, Z., Msandiwa, R., Milovanovic, M., Gordhan, B. G., Otwombe, K., Friedrich, S. O., Chaisson, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14650803
Li, S., Lin, L., Zhang, F., Zhao, C., Meng, H., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.12364664
Singh, K., Kumari, R., Gupta, S., Tripathi, R., Srivastava, A., Shakya, V., Gupta, A., & Anupurba, S. (2021) · Figshare · doi:10.6084/m9.figshare.16456734
Li, S., Lin, L., Zhang, F., Zhao, C., Meng, H., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.12364694
Li, S., Lin, L., Zhang, F., Zhao, C., Meng, H., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.12364658
Bahizi, G., Majwala, R. K., Kisaka, S. M. B., Nyombi, A., Musisi, K., Kwesiga, B., Bulage, L., Ario, A. R., & Turyahabwe, S. (2021) · Figshare · doi:10.6084/m9.figshare.14561358
Li, S., Lin, L., Zhang, F., Zhao, C., Meng, H., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.12364676
Sinha, P., Srivastava, G. N., Tripathi, R., Mishra, M. N., & Anupurba, S. (2020) · Figshare · doi:10.6084/m9.figshare.12965340
Li, S., Lin, L., Zhang, F., Zhao, C., Meng, H., & Wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.12364685
Studies on CD4+ T cell subsets in Mycobacterium tuberculosis immunity during HIV co-infection
Nesamari, R. (2023) · Open University of Cape Town (University of Cape Town)
Perez-Risco, D. (2021) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Tshokey, T., Choden, U., Choden, D., Dendup, S., Pheljay, S., Jamtsho, R., & Wangdi, K. (2026) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2026.01.006
Why a Mycobacterium Avium Infected Patient Showed a Positive Xpert MTB / RIF Result?
Chen, L., Tang, M., Wang, Q., & Jiang, H. (2026) · Clinical Case Reports · doi:10.1002/ccr3.71965
“Previous studies have shown that the Xpert test results are not affected by the presence of MAC [9], but high loads of NTM may generate false-positive Xpert MTB/RIF assays [10], posing a problem in the differential diagnosis of MTB and MAC.”
Metadata
- Authors
- Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., Safi, H., Blakemore, R., Lan, N. T. N., Jones-López, E. C., Levi, M., Burday, M., Ayakaka, I., Mugerwa, R. D., McMillan, B., Winn-Deen, E., Christel, L., Dailey, P., Perkins, M. D., Persing, D. H., & Alland, D.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Cepheid (United States) (US)
- Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry, New Jersey, Newark, New Jersey
- FIND (CH)
- Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Montefiore Medical Center (US)
- Makerere University (UG)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 48
- Issue
- 1
- Pages
- 229-237
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC2812290
- OpenAlex
- W2112022845
- Cited by
- 914
- References
- 59
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 35 · 2023: 33 · 2022: 36 · 2021: 45 · 2020: 65 · 2019: 55 · 2018: 61 · 2017: 62 · 2016: 63 · 2015: 62 · 2014: 74 · 2013: 71 · 2012: 62
- FWCI
- 41.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R41AI052523, R42AI052523, R42-AI52523, R41-AI52523)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis detection, rifampicin resistance, Xpert MTB/RIF, point-of-care testing, real-time PCR, sputum, detection limit, nontuberculous mycobacteria, retreatment tuberculosis, tuberculosis diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Bacteriological Techniques, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Sputum, Tuberculosis, Uganda, Vietnam, Polymerase Chain Reaction, Point-of-Care Systems, Drug Resistance, Bacterial, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.